About MEDIVASA s r o
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
4
Pfizer
3
Boehringer Ingelheim
2
Cogentus Pharmaceuticals
1
Daiichi Sankyo, Inc.
1
Eli Lilly and Company
1
Ilkos Therapeutic Inc.
1
Kowa Research Institute, Inc.
1
Resverlogix Corp
1
Clinical Trials at MEDIVASA s r o
During the past decade, MEDIVASA s r o conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 7 clinical trials were completed, i.e. on
average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
2007-12-01
2009-11-01
Terminated
5,000
Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects
2008-04-01
2015-04-01
Completed
791
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "MEDIVASA s r o" #1 sponsor was "Bayer" with 4 trials, followed by "Pfizer" with 3 trials
sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Cogentus Pharmaceuticals" with 1 trials sponsored and "Daiichi Sankyo, Inc."
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "MEDIVASA s r o"
#1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at MEDIVASA s r o
According to Clinical.Site data, the most researched conditions in "MEDIVASA s r o" are
"Diabetes Mellitus, Type 2" (3 trials), "Atrial Fibrillation" (2 trials), "Coronary Artery Disease" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "MEDIVASA s r o" in a lesser frequency.
Clinical Trials Intervention Types at MEDIVASA s r o
Most popular intervention types in "MEDIVASA s r o" are "Drug" (14 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Apabetalone" (1 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MEDIVASA s r o
The vast majority of trials in "MEDIVASA s r o" are
15 trials for "All" genders.
Clinical Trials Status at MEDIVASA s r o
Currently, there are NaN active trials in "MEDIVASA s r o".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in MEDIVASA s r o,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in MEDIVASA s r o, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".